Dr. Tobias Deuse, MD

Dr. Deuse practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Deuse's NPI, 1518152149, was assigned on September 6, 2007. Dr. Deuse graduated from University of Wurzburg Faculty of Medicine in 2000. Dr. Deuse holds California license F5411.

Dr. Deuse's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Deuse's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Deuse is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is UCSF Medical Group. Dmand AI also links Dr. Deuse to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deuse practices, 2 sites in all. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. Deuse's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. Deuse is licensed in California.

Dmand AI lists heart bypass surgery and heart valve surgery among the conditions Dr. Deuse treats.

CMS data shows 108 Medicare services from Dr. Deuse across 4 procedure codes in 2024, for 134 Medicare patients. Medicare paid $64,157 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 134 Medicare patients who saw Dr. Deuse in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deuse's median patient age at 68, with 46% women.

In 2024, Dr. Deuse wrote 131 Medicare Part D claims for 22 patients. 82% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $1,180 in total drug cost. In 2022, CMS named 20 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Deuse for performance year 2024, reported as part of a group. Dr. Deuse accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Deuse as offering telehealth.

Coronary artery bypass graft (CABG): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 163 papers to Dr. Deuse, published from 2005 to 2025. 2018 was the busiest year, with 8. The most frequent topics are Graft Rejection, Heart Transplantation and Heart-Assist Devices. Dr. Deuse has published most often in Transplantation. Dr. Deuse's most frequent co-authors are Robert Robbins, MD, Ramin E. Beygui, MD and Andrew James Connolly.

CMS Open Payments shows 64 general payments to Dr. Deuse from 8 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 67% of the total. Edwards Lifesciences Corporation paid the most, $2,375.

Dr. Deuse graduated from University of Wurzburg Faculty of Medicine in 2000.

Dr. Deuse is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.